Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 1/2008

01-01-2008 | Original Paper

Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany

Authors: Gisela Schott, Margrit Reichel, Hans Junkermann, Nikolaus Becker

Published in: Journal of Cancer Research and Clinical Oncology | Issue 1/2008

Login to get access

Abstract

Several parameters for quality assurance of mammography screening require background incidence rates, i.e. the breast cancer incidence in the absence of screening. For new programmes, incidence rates for the years prior to the programme are usually taken as a substitute with the appropriate source being cancer registries. In Germany, the feasibility of quality-assured screening was examined in three pilot projects over the years 2001–2005, so that background incidence was needed for quality assurance. Since countrywide cancer registration was not yet well established and especially in the pilot area of Wiesbaden an active cancer registry did not exist, other ways to obtain accurate rates were needed. Thus, in this pilot a manual data collection of breast cancer cases from diagnosing pathologic institutes was conducted to quantify local breast cancer incidence and compare it with available regional registry data from a distant part of the country. Results showed large similarities of rates for the mid of the 1990s, but a stronger increase of incidence for the subsequent years specifically in the pilot area. This increase was likely related to particular efforts in favour of opportunistic screening in that area. They led to increased detection of small cancers, but were too unsystematic to initiate decline of advanced breast cancers on the population level. In view of getting appropriate figures for background incidence these results indicate that emphasis should be put on using rates which are less affected by opportunistic screening rather than obtaining geographically proximate data. We propose to use the 50–69 years incidence rate of breast cancer for the years 1996–2000 in the Saarland cancer registry as background incidence rate which is almost identical to the Wiesbaden data for 1996 and 1997 but increased less strongly during 1998–2000. This incidence rate is 2.5 per 1,000, while that found in the Wiesbaden area was 2.7 per 1,000.
Literature
go back to reference Day NE, Williams DRR, Khaw KT (1989) Breast cancer screening programmes: the development of a monitoring and evaluation system. Int J Cancer 59:954–958 Day NE, Williams DRR, Khaw KT (1989) Breast cancer screening programmes: the development of a monitoring and evaluation system. Int J Cancer 59:954–958
go back to reference Frischbier HJ, Hoeffken W, Robra BP (1994) Mammography in early detection of cancer (in German). Enke, Stuttgart Frischbier HJ, Hoeffken W, Robra BP (1994) Mammography in early detection of cancer (in German). Enke, Stuttgart
go back to reference Giersiepen K, Haartje U, Hentschel S, Katalinic A, Kieschke J (2004) Stage distribution in the target population of mammography screening (in German). Deutsches Ärzteblatt A 101(30):2117–2122 Giersiepen K, Haartje U, Hentschel S, Katalinic A, Kieschke J (2004) Stage distribution in the target population of mammography screening (in German). Deutsches Ärzteblatt A 101(30):2117–2122
go back to reference Junkermann H, Becker N, Peitgen H-O (2001) German pilot projects of mammography screening (in German). Der Radiologe 41:328–336PubMedCrossRef Junkermann H, Becker N, Peitgen H-O (2001) German pilot projects of mammography screening (in German). Der Radiologe 41:328–336PubMedCrossRef
go back to reference Katalinic (2004) Population-based cancer registration in Germany. Essentials and perspectives (in German) Bundesgesundheitsblatt 47:422–428CrossRef Katalinic (2004) Population-based cancer registration in Germany. Essentials and perspectives (in German) Bundesgesundheitsblatt 47:422–428CrossRef
go back to reference Köhler A, Gibis B, Mühlich A (2003) Mammographie-Screening. Flächendeckendes Angebot bereits im Jahr 2005. Dtsch Ärztebl A 100:1240–1243 (Heft 19) Köhler A, Gibis B, Mühlich A (2003) Mammographie-Screening. Flächendeckendes Angebot bereits im Jahr 2005. Dtsch Ärztebl A 100:1240–1243 (Heft 19)
go back to reference Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in five continents, vol VIII. IARC Scientific Publications No. 155. International Agency for Research on Cancer, Lyon Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in five continents, vol VIII. IARC Scientific Publications No. 155. International Agency for Research on Cancer, Lyon
go back to reference Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, Puthaar E (eds) (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, Puthaar E (eds) (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg
go back to reference Rittgen W, Becker N (2000) SMR-analysis of historical follow-up studies with missing death certificates. Biometrics 56:1164–1169PubMedCrossRef Rittgen W, Becker N (2000) SMR-analysis of historical follow-up studies with missing death certificates. Biometrics 56:1164–1169PubMedCrossRef
Metadata
Title
Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany
Authors
Gisela Schott
Margrit Reichel
Hans Junkermann
Nikolaus Becker
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 1/2008
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-007-0239-4

Other articles of this Issue 1/2008

Journal of Cancer Research and Clinical Oncology 1/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.